Insurance for Life Sciences by Life Sciences Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life sciences markets:

Digital Health Companies

Companies that focus on the convergence of technology and healthcare, developing digital devices, software applications, and online platforms, improving connectivity and spanning a wide range of uses.

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments, digital health products, and devices for healthcare applications.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Contract Manufacturing/Contract Design Manufacturing

Companies that provide outsourced manufacturing services for life sciences companies, producing pharmaceutical, biotech, medical device, or diagnostic products either to client specifications or through their own design and engineering capabilities.

Contract Research Organizations (Clinical and Pre Clinical)

Companies that provide outsourced research services to pharmaceutical, biotechnology, and medical device companies by designing, managing, and conducting laboratory studies, animal studies, and human clinical trials to support the development, regulatory approval, and commercialization of new products.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life sciences business by life sciences specialists?

Find an Agent

The Latest in Life Science

A Decade After the Ice Bucket Challenge: Progress in ALS Research

More than a decade after millions of people, from movie stars and athletes to everyday individuals, dumped ice water over their heads in support of amyotrophic lateral sclerosis (ALS), the movement’s long-term impact on research, care, and public awareness is becoming clear.

Beyond the Label: Will FDA’s ACNU Framework Transform Nonprescription Access?

Imagine walking into your local pharmacy without a prescription and purchasing a medication that traditionally required one after completing a questionnaire or similar screening process. Medications that previously depended on practitioner involvement could become more accessible if consumers successfully complete safeguards approved by the Food and Drug Administration (FDA). That possibility is at the center of FDA’s Additional Condition for Nonprescription Use (ACNU) framework.

Beyond Weight Loss: How the GLP-1 Conversation Continues to Evolve

In a recent article, we examined the regulatory, litigation, and compliance developments surrounding GLP-1 therapies. As these medications have become more widely used, discussions across healthcare, research, and industry have expanded beyond their original role in diabetes treatment and weight management.